Back To Search Results

Oral Management of Patients Undergoing Radiation Therapy

Editor: Melina Brizuela Updated: 3/19/2023 2:00:56 PM

Introduction

Radiotherapy is a widely used treatment modality for managing carcinomas in the head and neck region, either alone or combined with chemotherapy. Head and neck cancer includes malignancies of the oral cavity, pharynx, larynx, salivary glands, paranasal sinuses, and nasal cavity. Most of these carcinomas are derived from the squamous epithelium of these regions.[1]

Although effective in managing malignancies, radiotherapy induces undesirable side effects in the oral cavity. Some develop soon after initiating treatment, and others may appear after months or even years of completion of treatment. Oral complications of radiotherapy mainly include oral mucositis, xerostomia, dysgeusia, oropharyngeal candidiasis, radiation-related caries, and osteoradionecrosis.[1] 

All of these complications may impair eating, swallowing, and speaking, with consequent loss of weight and appetite. Severe cases require parental nutrition and pausing radiation treatment, significantly affecting patients' prognosis. Dental management strategies must be implemented before, during, and after radiotherapy to prevent or decrease the severity of these debilitating conditions.[2] Therefore, having a dental professional in the oncology team treating head and neck cancer patients will significantly alleviate the detrimental effect of oral complications and improve patients' basic life functions and quality of life.[3]

Function

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Function

Radiation Therapy Biology

Radiation therapy uses ionizing radiation to damage malignant cells by acting on the DNA, leading to cellular death or inhibiting their multiplication capacity.[4] Although several types of ionizing radiation exist, most treatments use photons.[5] Radiation can be delivered by external beam radiation (from outside the body) or brachytherapy (from inside the body). External beam radiation is more common, and brachytherapy is implemented mainly in gynecological and prostate cancers.

Radiotherapy can be used to cure or alleviate symptoms caused by malignancy; it can be given in combination with surgery, immunotherapy, or chemotherapy.[4] When radiation is given pre-surgery, it usually has the objective of decreasing the size of the tumor. When it is given after surgery, it aims at eliminating residual microscopic malignant cells.[4]

Radiotherapy works on the principle of damaging the genetic material of cells (DNA), acting on both cancerous and normal cells. During mitosis, the DNA content of cells duplicates; therefore, cells with high mitotic activity are more susceptible to radiation than those with low mitotic activity. In other words, tissues with higher division activity are more radiosensitive, which is usually the case with malignant tumors. Different tumors have different multiplication capacities, making some more radiosensitive than others.[5]

Normal tissues located in the radiation path also suffer the effects of ionizing radiation, which in the oral cavity leads to complications such as oral mucositis, xerostomia, and radiation-related caries. However, normal cells have a faster repair rate and a better ability to return to normal function than cancerous cells. The lower repair rate of cancerous cells is what causes differential malignant cell killing.[5] 

The newer radiotherapy modalities like 3-D confrontation therapy, intensity modulated therapy (IMRT), and proton beam therapy can deliver radiation to localized areas, thus, sparing the normal tissue more efficiently.[6]

Issues of Concern

Oral Complications of Radiation Therapy in The Head and Neck

Oral Mucositis

Oral mucositis is a frequent complication of head and neck radiation therapy (RT), occurring in up to 91% of patients.[7] It also develops as an adverse effect of chemotherapy in 20 to 40% of cases.[8] The basal layer of the oral epithelium has a high mitotic activity, making it more susceptible to radiation injury, and leading to oral mucositis.[9] Symptoms usually appear after the first week of RT and may last for several months.[2]

Oral lesions include erythema, atrophy, swelling, and ulcerations that may be covered by pseudomembranes. Patients report debilitating pain, loss of taste, eating, drinking, and speaking difficulties, which may require parental nutrition.[2] Radiation treatment has sometimes to be paused, affecting the overall prognosis of the malignancy.[10] Oral mucositis usually resolves within two to three weeks after finishing radiotherapy.[10][11][3]

Xerostomia

Xerostomia is an expected side effect of radiotherapy on the head and neck, which starts soon after initiating treatment and may be irreversible in some cases.[1] The salivary glands are susceptible to radiation, and even low doses to the head and neck can cause cell death and fibrosis, leading to gland dysfunction.[2]

Salivary gland damage results in hyposalivation (decreased salivary flow) and thickening of the saliva, perceived as xerostomia. This causes speaking, eating, and swallowing difficulties and affects taste perception. Also, a decreased salivary flow makes the oral cavity more vulnerable to candidiasis, gingivitis, and dental caries.[2]

Oropharyngeal Candidiasis

Patients undergoing radiation therapy for head and neck cancer are at an increased risk of developing fungal infections. This may be a consequence of the salivary flow reduction experienced during radiation therapy [1] and possibly, also due to a decreased phagocytic activity of salivary granulocytes.[5]

Clinically, radiation-related oropharyngeal candidiasis may present as pseudomembranous, erythematous, or angular cheilitis.[12] The erythematous forms are harder to diagnose as they may be confused with radiotherapy-induced oral mucositis. Oral candidiasis most commonly presents as a scrapable white pseudomembrane or erythematous patch on the tongue, commissures, and palate.[5] Patients usually report a burning sensation in the mouth, dysgeusia, and halitosis. The occurrence of oral candidiasis depends on the salivary flow rate, oral hygiene status, and, if present, the severity of oral mucositis.[13]

Dysgeusia

Dysgeusia is an unpleasant or abnormal alteration of taste, frequently described as metallic.[3] Infections, head and neck trauma or surgery, drugs, and radiotherapy have been identified to cause dysgeusia.[14]

Altered taste perception is reported by about 70% of patients receiving radiotherapy, which is also linked to loss of appetite and weight. Symptoms appear after the second or third week of treatment, and taste perception usually goes back to normal 60 to 120 days after finishing radiotherapy.[5]

Radiation-related Caries

Radiation-related caries is a very aggressive type of tooth decay that develops in dental surfaces normally refractive to caries.[15] The labial surfaces of the cervical areas are mostly involved.[2] The lingual aspect of lower anterior teeth, which are not normally prone to caries, are also affected by radiation-related caries.[16] The etiology is not well understood, but it is believed to be caused by the decreased salivary flow levels experienced during radiotherapy and direct radiation damage to the dental structures.[16]

Radiation caries are generalized and precipitate about six to twelve months after head and neck radiation treatment. Lesions usually begin as enamel cracks and fractures and evolve into brown-black enamel discoloration.[16] If the lesions are not diagnosed and treated promptly, they will soon progress to incisal-cuspal wear and widespread cervical caries, eventually leading to the amputation of the crown.[16]

Osteoradionecrosis (ORN)

Osteoradionecrosis (ORN) of the jaws is a late complication of radiation therapy of the head and neck, where exposed irradiated bone becomes necrotic and fails to heal for at least three months with no signs of tumor recurrence.[17] The condition mainly affects the mandible and rarely develops in the maxilla.[2] 

Risk factors include poor oral health and hygiene, pre-head and neck radiation surgery, dental surgery, and tobacco and alcohol consumption.[3] The risk of ORN is also incremented when the radiation dose exceeds 60 Gy.[18] Osteoradionecrosis clinically presents as exposed bone with or without mucosal dehiscence, and as the condition advances, intraoral and extraoral fistula and later pathological fracture may develop.

Clinical Significance

Pre-radiotherapy Dental Management

Pre-radiation dental treatment is done to prevent further infection and avoid the need for invasive procedures during and after radiotherapy. All efforts are directed at minimizing the risk and severity of head and neck radiotherapy complications: oral mucositis, oropharyngeal candidiasis, xerostomia, radiation-related caries, and osteoradionecrosis.

During this stage, patients must be informed of the importance of maintaining excellent oral hygiene and given careful oral care instructions and dietary advice. All carious lesions must be restored. Scaling, oral prophylaxis, and periodontal therapy should be performed. All sharp cusps and restorations should be smoothened.[2] If the patient wears dentures, these should be checked to ensure they are well-fitted and not at risk of causing ulceration.

If a definitive restoration cannot be placed due to time limitations, carious tissue must be removed and teeth restored with glass ionomer cement. Amalgam restorations should be avoided as they often backscatter and cause local mucosal irritation.[19]

Performing pre-radiation dental extractions is a controversial topic since the evidence available is contradictory. Some studies have shown that pre-radiation extractions may increase the risk of osteoradionecrosis, and others show that the lack of pre-radiation extractions increases this risk too. If extractions are performed before the first cycle of radiation therapy, the ideal interval between extraction and the beginning of RT should be between ten days and three weeks so that complete soft tissue healing occurs.[2]

The urgency to start RT is a critical dictating factor in whether to extract teeth or not.[20] Radiation treatment should not be unnecessarily delayed as it diminishes a patient's survival. Wound dehiscence could be a limiting factor in delaying therapy at times. Daily wound dressing, irrigation, and antibiotic cover may hasten the process.

Finally, obtaining dental impressions pre-radiation therapy for study models that will be useful for fabricating soft mouth guards or medicament-carrying trays is recommended.[2]

Management of Oral Complications During Radiotherapy

Oral Mucositis

Uncomplicated oral mucositis is usually self-limiting, and palliative care tends to be sufficient.[8] The main management recommendations include basic oral care, dietary advice, and pain control. Low-level laser therapy is also recommended to prevent or reduce the severity of oral mucositis in adult patients receiving radiotherapy alone or in combination with chemotherapy.[21]

Basic oral care includes enhancing the patient's oral hygiene (increasing frequency of tooth brushing, clean interproximally, using soft brushes, and replacing the toothbrush more often); rinsing the oral cavity with bland rinses like saline water or sodium bicarbonate every four hours; lubricating the oral mucosa using mousses or topical barrier gels, and avoiding irritants like tobacco or alcohol.[8]

Foods that may unintendedly injure or irritate the oral mucosa must be avoided, such as hard, sharp, and spicy food.[8] Consultation with a dietician to facilitate oral intake may be required. A bland, high-calorie, soft diet is recommended.[11]

MASCC/ISOO guidelines recommend topical morphine 0.2% for pain management.[21] Other formulations are available such as the "magic mouthwash," which contains an anesthetic, diphenhydramine, and antacid and may have steroids and anti-micotics.[8] However, topical morphine 0.2% has proven to be more efficient.[8]

Xerostomia

The aim of treatment is symptomatic relief, and management mainly includes patient education measures. Patients must be advised to frequently sip water, chew sugar-free gum, suck sugar-free candy, avoid caffeine, tobacco, alcohol, and hard or dry food, and increase fluid intake to prevent dehydration.[22] Bland rinses used for oral mucositis are also recommended for xerostomia to clean the oral tissues. Saliva substitutes are available, but they have limitations: short duration of action, unpleasant taste, unreliability, and high cost.

Pharmacological treatment is reserved for when local measures are ineffective. The systemic drugs pilocarpine and cevimeline are approved by the FDA for managing xerostomia.[22] They both work on muscarinic receptors. However, the adverse effects of these drugs limit their use; pilocarpine side effects include nausea, diarrhea, sweating, and rhinitis. Bronchospasm has also been reported.[22] Pilocarpine is contraindicated in patients with glaucoma, asthma, and hypertension.[23] Cevimeline also induces increased sweating and should be avoided in patients with glaucoma and cardiac issues.

Oropharyngeal Candidiasis

Oropharyngeal candidiasis is managed with topical treatment in milder cases, and systemic antifungals are indicated when disseminated candidiasis is suspected, the patient is at higher risk (myelosuppression, immunodeficiency) and upon failure of topical measures.

The first-line treatment includes topical fluconazole, miconazole, or nystatin. When systemic antifungals are indicated, fluconazole is the drug of choice. Generally, systemic therapy with fluconazole is more efficient than topical antifungals in patients with cancer.[3] Patients should be advised to maintain excellent oral hygiene, lubricate the oral mucosa, and avoid tobacco and alcohol consumption.[2]

Management of Oral Complications After Radiotherapy

Radiation-related Caries

Prevention, early detection, and treatment are vital. The risk of radiation caries should be explained to patients before, during, and after radiation therapy. Prevention regimens must be implemented immediately after the cancer diagnosis.[16] Patients must be referred to a dental professional for a complete check-up.[16] During this stage, the oral needs are identified and treated: new restorations, adjustment of old restorations, endodontic and periodontal treatment, and extraction of unrestorable teeth.[16]

The importance of maintaining excellent oral hygiene must be emphasized, including gentle tooth brushing with a soft-bristled toothbrush twice or four times per day, interproximal cleaning, and fluoride supplementation.[16] Sodium bicarbonate rinses are also recommended.[2] Fluoride trays and topical fluoride applications significantly reduce the risk of radiation caries.[2] Prescription fluoride should be utilized minimally twice per day. Furthermore, as radiation caries are believed to be partly caused by hyposalivation, managing xerostomia is essential.[2]

The restoration of radiation caries poses a tremendous challenge to the dentist, mainly due to limited mouth opening, poor access and visibility, and changes in the tooth structure that alter the adhesive properties of dental materials.[15] Resin-modified glass ionomer cement (GIC) is a good option to restore these teeth due to its fluoride-releasing property. It also has a quick and simple bonding procedure and better strength than conventional GIC.[24][25]

When the pulp is involved, endodontic treatment is preferred over extraction.[15] Root canal treatment can be a more appropriate option, even in unrestorable teeth, to control the infection and symptoms and decrease the risk of osteoradionecrosis. However, limited mouth opening and difficulty in rubber dam isolation may pose a few challenges, like doing a suitable access cavity.[2]

Some authors suggest opening the tooth through the vestibular or incisal surfaces or decoronating teeth with gross caries to improve access.[2] If extraction is unavoidable minimal trauma technique by an experienced dental surgeon should be done. A limited number of teeth should be removed in a single visit.[2]

Osteoradionecrosis

The mainstay of osteoradionecrosis treatment is prevention. Oral health should be stabilized before radiotherapy. All necessary dental and periodontal interventions must be performed, oral hygiene instructions carefully instructed, and oral health closely monitored before, during, and after radiation treatment. This is to avoid infection and the need for invasive procedures during and after radiation treatment.[3]

If a tooth is deemed unrestorable, it is recommended that endodontic treatment is tried first. If extraction becomes unavoidable, general practitioners can extract teeth located outside the radiation field, or if in the radiation field, the dose must be less than 50 Gy.[2] However, referral to the oral and maxillofacial surgery department must be made when teeth are in radiation fields of more than 50 Gy.[2]

The patient must be referred to a tertiary maxillofacial department for treatment if osteoradionecrosis is diagnosed.[2] The condition can be managed with conservative measures, ranging from oral hygiene improvement, antibiotics, and analgesics, to sequestrectomy, ultrasound, and hyperbaric oxygen therapy.[26] 

The need for more radical surgical management depends on the severity of the condition.[26] Pharmacological treatment with pentoxifylline, clodronate, or tocopherol, can also be indicated as adjuvants.[27]

Other Issues

Recurrence of Cancer

Chronic nonhealing ulcers with indurated margins usually indicate recurrence.[28] Suspicious cases should be biopsied and sent for histopathological examination.[28]

Enhancing Healthcare Team Outcomes

The management of head and neck cancer involves oncologists, radiotherapists, dental practitioners, dental hygienists, nurses, dieticians, and a counselor.[20][29][30] Communication between the dentist and the oncology radiotherapist regarding the treatment plan is important, e.g., the area covered in the radiation field, unilateral or bilateral salivary gland involvement, and radiation dose.[30] 

Often, it is a race against time to start therapy and treat the dental ailment. During the therapy usually, complications are handled by radiotherapists and nurses, and dental inputs can help to manage the condition better. The need for meticulous planning by the dentist and discussion with other professionals involved in managing the patient is highly recommended to lower morbidity and improve outcomes.[30]

While delivering radiation treatment in the head and neck region, pre-RT dental management, along with management of adverse effects during and after RT, can have a major effect on the patient's quality of life.[30][31] For good treatment outcomes, interprofessional communication between a dentist who specializes in dealing with patients with head and neck cancer, an oncologist, and a radiotherapist is vital.[30]

Nursing, Allied Health, and Interprofessional Team Interventions

Since oral intake is compromised because of complications like radiation mucositis and limited mouth opening, the role of dietitians is important.[32] Communication with the treating dentist and dental hygienists is important as a high-carbohydrate diet may predispose to radiation caries.[32] The role of nurses in radiation therapy patients can range from educating about self-care and providing psychosocial support to collaborating with the treating physician in managing adverse effects.[33]

Proper training and expertise of nurses can provide better care.[33] The dentist should also train the spouse or other caretaker family members in maintaining excellent oral hygiene.[34][35] Counseling by psychologists can help patients in overcoming stress because of compromised quality of life.[34][35]

References


[1]

Kawashita Y, Soutome S, Umeda M, Saito T. Oral management strategies for radiotherapy of head and neck cancer. The Japanese dental science review. 2020 Dec:56(1):62-67. doi: 10.1016/j.jdsr.2020.02.001. Epub 2020 Feb 20     [PubMed PMID: 32123547]


[2]

Beech N, Robinson S, Porceddu S, Batstone M. Dental management of patients irradiated for head and neck cancer. Australian dental journal. 2014 Mar:59(1):20-8. doi: 10.1111/adj.12134. Epub 2014 Feb 4     [PubMed PMID: 24495127]


[3]

Sroussi HY, Epstein JB, Bensadoun RJ, Saunders DP, Lalla RV, Migliorati CA, Heaivilin N, Zumsteg ZS. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis. Cancer medicine. 2017 Dec:6(12):2918-2931. doi: 10.1002/cam4.1221. Epub 2017 Oct 25     [PubMed PMID: 29071801]


[4]

Baskar R,Lee KA,Yeo R,Yeoh KW, Cancer and radiation therapy: current advances and future directions. International journal of medical sciences. 2012     [PubMed PMID: 22408567]

Level 3 (low-level) evidence

[5]

Jham BC, da Silva Freire AR. Oral complications of radiotherapy in the head and neck. Brazilian journal of otorhinolaryngology. 2006 Sep-Oct:72(5):704-8     [PubMed PMID: 17221065]


[6]

Alfouzan AF, Radiation therapy in head and neck cancer. Saudi medical journal. 2021 Mar     [PubMed PMID: 33632902]


[7]

Brown TJ, Gupta A. Management of Cancer Therapy-Associated Oral Mucositis. JCO oncology practice. 2020 Mar:16(3):103-109. doi: 10.1200/JOP.19.00652. Epub 2020 Feb 3     [PubMed PMID: 32048926]


[8]

Bell A,Kasi A, Oral Mucositis StatPearls. 2022 Jan     [PubMed PMID: 33351407]


[9]

Sonis ST. The pathobiology of mucositis. Nature reviews. Cancer. 2004 Apr:4(4):277-84     [PubMed PMID: 15057287]


[10]

Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral oncology. 2010 Jun:46(6):452-6. doi: 10.1016/j.oraloncology.2010.03.012. Epub 2010 Apr 18     [PubMed PMID: 20403721]


[11]

Murdoch-Kinch CA, Zwetchkenbaum S. Dental management of the head and neck cancer patient treated with radiation therapy. The Journal of the Michigan Dental Association. 2011 Jul:93(7):28-37     [PubMed PMID: 21888251]


[12]

Lalla RV,Latortue MC,Hong CH,Ariyawardana A,D'Amato-Palumbo S,Fischer DJ,Martof A,Nicolatou-Galitis O,Patton LL,Elting LS,Spijkervet FK,Brennan MT,Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)., A systematic review of oral fungal infections in patients receiving cancer therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2010 Aug     [PubMed PMID: 20449755]

Level 1 (high-level) evidence

[13]

Karbach J, Walter C, Al-Nawas B. Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation. Clinical oral investigations. 2012 Aug:16(4):1305-12. doi: 10.1007/s00784-011-0612-1. Epub 2011 Sep 9     [PubMed PMID: 21904917]


[14]

Mortazavi H, Shafiei S, Sadr S, Safiaghdam H. Drug-related Dysgeusia: A Systematic Review. Oral health & preventive dentistry. 2018:16(6):499-507. doi: 10.3290/j.ohpd.a41655. Epub     [PubMed PMID: 30574604]

Level 1 (high-level) evidence

[15]

Gupta N, Pal M, Rawat S, Grewal MS, Garg H, Chauhan D, Ahlawat P, Tandon S, Khurana R, Pahuja AK, Mayank M, Devnani B. Radiation-induced dental caries, prevention and treatment - A systematic review. National journal of maxillofacial surgery. 2015 Jul-Dec:6(2):160-6. doi: 10.4103/0975-5950.183870. Epub     [PubMed PMID: 27390489]

Level 1 (high-level) evidence

[16]

Palmier NR,Migliorati CA,Prado-Ribeiro AC,de Oliveira MCQ,Vechiato Filho AJ,de Goes MF,Brandão TB,Lopes MA,Santos-Silva AR, Radiation-related caries: current diagnostic, prognostic, and management paradigms. Oral surgery, oral medicine, oral pathology and oral radiology. 2020 Jul     [PubMed PMID: 32444333]


[17]

Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. International dental journal. 2018 Feb:68(1):22-30. doi: 10.1111/idj.12318. Epub 2017 Jun 25     [PubMed PMID: 28649774]


[18]

Lang K, Held T, Meixner E, Tonndorf-Martini E, Ristow O, Moratin J, Bougatf N, Freudlsperger C, Debus J, Adeberg S. Frequency of osteoradionecrosis of the lower jaw after radiotherapy of oral cancer patients correlated with dosimetric parameters and other risk factors. Head & face medicine. 2022 Feb 26:18(1):7. doi: 10.1186/s13005-022-00311-8. Epub 2022 Feb 26     [PubMed PMID: 35219324]


[19]

Chin DWH, Treister N, Friedland B, Cormack RA, Tishler RB, Makrigiorgos GM, Court LE. Effect of dental restorations and prostheses on radiotherapy dose distribution: a Monte Carlo study. Journal of applied clinical medical physics. 2009 Feb 3:10(1):80-89. doi: 10.1120/jacmp.v10i1.2853. Epub 2009 Feb 3     [PubMed PMID: 19223833]


[20]

Devi S, Singh N. Dental care during and after radiotherapy in head and neck cancer. National journal of maxillofacial surgery. 2014 Jul-Dec:5(2):117-25. doi: 10.4103/0975-5950.154812. Epub     [PubMed PMID: 25937720]


[21]

Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P, Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1:126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28     [PubMed PMID: 32786044]

Level 1 (high-level) evidence

[22]

Talha B, Swarnkar SA. Xerostomia. StatPearls. 2023 Jan:():     [PubMed PMID: 31424871]


[23]

Strojan P, Hutcheson KA, Eisbruch A, Beitler JJ, Langendijk JA, Lee AWM, Corry J, Mendenhall WM, Smee R, Rinaldo A, Ferlito A. Treatment of late sequelae after radiotherapy for head and neck cancer. Cancer treatment reviews. 2017 Sep:59():79-92. doi: 10.1016/j.ctrv.2017.07.003. Epub 2017 Jul 18     [PubMed PMID: 28759822]


[24]

Hu JY, Li YQ, Smales RJ, Yip KH. Restoration of teeth with more-viscous glass ionomer cements following radiation-induced caries. International dental journal. 2002 Dec:52(6):445-8     [PubMed PMID: 12553399]


[25]

Palmier NR, Madrid Troconis CC, Normando AGC, Guerra ENS, Araújo ALD, Arboleda LPA, Fonsêca JM, de Pauli Paglioni M, Gomes-Silva W, Vechiato Filho AJ, González-Arriagada WA, Paes Leme AF, Prado-Ribeiro AC, Brandão TB, de Goes MF, Lopes MA, Santos-Silva AR. Impact of head and neck radiotherapy on the longevity of dental adhesive restorations: A systematic review and meta-analysis. The Journal of prosthetic dentistry. 2022 Nov:128(5):886-896. doi: 10.1016/j.prosdent.2021.02.002. Epub 2021 Mar 11     [PubMed PMID: 33715834]

Level 1 (high-level) evidence

[26]

Rice N, Polyzois I, Ekanayake K, Omer O, Stassen LF. The management of osteoradionecrosis of the jaws--a review. The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 2015 Apr:13(2):101-9. doi: 10.1016/j.surge.2014.07.003. Epub 2014 Jul 30     [PubMed PMID: 25084627]


[27]

Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. International journal of radiation oncology, biology, physics. 2011 Jul 1:80(3):832-9. doi: 10.1016/j.ijrobp.2010.03.029. Epub 2010 Jul 16     [PubMed PMID: 20638190]


[28]

da Silva SD, Hier M, Mlynarek A, Kowalski LP, Alaoui-Jamali MA. Recurrent oral cancer: current and emerging therapeutic approaches. Frontiers in pharmacology. 2012:3():149. doi: 10.3389/fphar.2012.00149. Epub 2012 Jul 30     [PubMed PMID: 23060791]


[29]

Kelly SL, Jackson JE, Hickey BE, Szallasi FG, Bond CA. Multidisciplinary clinic care improves adherence to best practice in head and neck cancer. American journal of otolaryngology. 2013 Jan-Feb:34(1):57-60. doi: 10.1016/j.amjoto.2012.08.010. Epub     [PubMed PMID: 23218113]

Level 2 (mid-level) evidence

[30]

Bertl K, Savvidis P, Kukla EB, Schneider S, Zauza K, Bruckmann C, Stavropoulos A. Including dental professionals in the multidisciplinary treatment team of head and neck cancer patients improves long-term oral health status. Clinical oral investigations. 2022 Mar:26(3):2937-2948. doi: 10.1007/s00784-021-04276-x. Epub 2021 Nov 18     [PubMed PMID: 34792667]


[31]

Thanvi J, Bumb D. Impact of dental considerations on the quality of life of oral cancer patients. Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology. 2014 Jan:35(1):66-70. doi: 10.4103/0971-5851.133724. Epub     [PubMed PMID: 25006287]

Level 2 (mid-level) evidence

[32]

Orell H, Schwab U, Saarilahti K, Österlund P, Ravasco P, Mäkitie A. Nutritional Counseling for Head and Neck Cancer Patients Undergoing (Chemo) Radiotherapy-A Prospective Randomized Trial. Frontiers in nutrition. 2019:6():22. doi: 10.3389/fnut.2019.00022. Epub 2019 Mar 18     [PubMed PMID: 30937304]

Level 1 (high-level) evidence

[33]

Tsuchihashi Y, Matsunari Y, Kanamaru Y. Survey of Difficult Experiences of Nurses Caring for Patients Undergoing Radiation Therapy: An Analysis of Factors in Difficult Cases. Asia-Pacific journal of oncology nursing. 2018 Jan-Mar:5(1):91-98. doi: 10.4103/apjon.apjon_48_17. Epub     [PubMed PMID: 29379840]

Level 3 (low-level) evidence

[34]

Kristanti MS, Setiyarini S, Effendy C. Enhancing the quality of life for palliative care cancer patients in Indonesia through family caregivers: a pilot study of basic skills training. BMC palliative care. 2017 Jan 17:16(1):4. doi: 10.1186/s12904-016-0178-4. Epub 2017 Jan 17     [PubMed PMID: 28095837]

Level 2 (mid-level) evidence

[35]

Badr H, Yeung C, Lewis MA, Milbury K, Redd WH. An observational study of social control, mood, and self-efficacy in couples during treatment for head and neck cancer. Psychology & health. 2015:30(7):783-802. doi: 10.1080/08870446.2014.994633. Epub 2015 Jan 2     [PubMed PMID: 25471820]

Level 2 (mid-level) evidence